Shareholding for the Period Ended December 31, 2015
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here03-02-2016
03-02-2016
Board Intimation for Results & Closure of Trading Window
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 11, 2016, to consider and approve the quarterly unaudited financial results for the aforesaid quarter.Further, the trading window will remain close for the Directors, Promoters, Designated Persons and the Connected Persons from the date of this letter and shall reopen after the expiry of 48 hours from the time the result becomes generally available.02-02-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Lincoln Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.19-01-2016
Tanzania bans Lincoln Pharma's bacteria-fighting injection
The company's registration has also been cancelled there18-01-2016
Chloramphenicol Sodium Succinate Injection banned
Lincoln Pharmaceuticals Ltd has informed BSE regarding "Chloramphenicol Sodium Succinate Injection banned".18-01-2016
Limited Review Report for Sept 30, 2015
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended September 30, 2015.05-11-2015
Financial Results for Sept 30, 2015
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended September 30, 2015.05-11-2015
Updates on Outcome of AGM
Lincoln Pharmaceuticals Ltd has submitted to BSE a copy of Proceedings of the Annual General Meeting (AGM) of the Company held on September 30, 2015.28-10-2015
Board Intimation for Results & Closure of Trading Window
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 05, 2015, to consider and approve the quarterly un-audited financial results for the aforesaid quarter.In view of above, the trading window will remain close from October 27, 2015 and shall reopen after the expiry of 48 hours from the time of publication of the results.27-10-2015
Shareholding Pattern for September 30, 2015
Lincoln Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015.14-10-2015